Todd Shriber

Todd Shriber

InvestorPlace Contributor

Recent Articles

Dow Jones Today: Lowered Fatality Forecasts Sent Stocks Higher

By Todd Shriber, InvestorPlace Contributor

Stocks got a lift on comments that novel coronavirus deaths could be lower than expected, potentially setting the stage for more upside.

Dow Jones Today: Rally Renews on Hopes of Reopening Economy

By Todd Shriber, InvestorPlace Contributor

Following a disappointing end to Tuesday's session, stocks rallied anew on Wednesday amid talk the White House is in talks about reopening the shuttered U.S. economy as the number of coronavirus cases plateaus.

Dow Jones Today: Bullish Possibilities on Hopes Coronavirus Is Peaking

By Todd Shriber, InvestorPlace Contributor

Over the past two days, leadership is being sourced from the names most severely punished in the coronavirus downturn, including airlines, casino and cruise line operators and hoteliers. The read-in is that investors are willing to wager that when the coronavirus issue subsides, there will be pent up demand to get out of the house and get back to enjoying life.

Dow Jones Today: Signs of Virus Easing Spark Wall Street Rally

By Todd Shriber, InvestorPlace Contributor

The Dow notched its biggest advance in more than a week Monday, but investors should beware getting carried away. Yes, these gains are important, but remember that this week could be the worst in terms of COVID-19 fatalities.

Moderna Emerges as Coronavirus Vaccine Leader

By Todd Shriber, InvestorPlace Contributor

Even with the sense of urgency surrounding coronavirus treatments, developers need to worth their way through the regulatory process, one that dictates it could be a year or more before a COVID-19 vaccine, such as Moderna's mRNA-1273, could be made available to patients. As such, it could be another couple of months before the company's Phase 1 data is made public.

Load More